Genscript Biotech Corporation (HKG:1548)
Hong Kong · Delayed Price · Currency is HKD 34.44
+1.08 (3.24%)
Aug 21, 2026, 4:08 PM HKT
Genscript Biotech Stock Forecast
Stock Price Forecast
According to 8 analysts polled by S&P Global, Genscript Biotech stock has a consensus rating of "Strong Buy" and an average price target of $29.17. The average 1-year stock price forecast is 15.30% lower than the current stock price, while the lowest is $15.91 (-53.80%) and the highest is $36.07 (+4.73%).
Price Target: $29.17 (-15.30%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Genscript Biotech stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 6 | 6 | 6 | 6 | 6 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 8 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Guotai Haitong No rating | Guotai Haitong | Buy Maintains $34.51 | Buy | Maintains | $34.51 | +0.20% | Aug 21, 2026 |
| Jefferies | Jefferies | Buy Maintains $30.00 | Buy | Maintains | $30.00 | -12.89% | Aug 20, 2026 |
Unknown Analyst CSC Financial No rating | CSC Financial | Buy Maintains $48.22 | Buy | Maintains | $48.22 | +40.01% | Aug 20, 2026 |
Unknown Analyst BOCOM International Holdings Company No rating | BOCOM International Holdings Company | Buy Maintains $32.20 | Buy | Maintains | $32.20 | -6.50% | Aug 20, 2026 |
Unknown Analyst Huatai Securities No rating | Huatai Securities | Buy Maintains $36.08 | Buy | Maintains | $36.08 | +4.76% | Aug 19, 2026 |
Financial Forecast
Revenue This Year
884.95M
from 959.53M
Decreased by -7.77%
Revenue Next Year
1.07B
from 884.95M
Increased by 21.13%
EPS This Year
0.05
from 0.11
Decreased by -55.92%
EPS Next Year
0.08
from 0.05
Increased by 65.49%
EPS and Forward PE are based on non-GAAP adjusted numbers.